TCTAP 2023 Sponsors

Yuhan Corporation

Logo
Yuhan¡¯s story began with Dr. Ilhan New¡¯s commitment to his country: to provide his fellow Koreans with the best medications and treatments available. Now, over 90 years later, the spirit of our founder continues to drive Yuhan forward as we reach out to the world, to improve the health and well-being of people everywhere. Yuhan¡¯s willow tree, the literal translation of Dr. New¡¯s surname, has become our symbol of integrity. It represents not only the quality of our products, but the ethics, transparency and social responsibility of our management philosophy as well.
Yuhan is prepared, with new ideas and methods, to take the lead toward a future filled with new pharmaceutical discoveries and continuing growth. As we endeavor to earn the trust of our customers and uphold our social responsibilities, Yuhan will create greater value for our stakeholders through ongoing innovation and international expansion.
Yuhan will always be with you to create a healthier and more prosperous society.

Exhibition Item

Rosuvamibe, Twynsta

Satellite Symposium

Lunchtime Activities

Empagliflozin¡¯s Winning Trajectory in Heart Failure

Organized by CVRF and Supported by Educational Grant from Yuhan Corporation & Boehringer Ingelheim & Lilly Korea

Tuesday, May 9
12:30 PM ~ 1:30 PM * KST (UTC/GMT +9:00)
Presentation Theater 1, Vista 3, B2
Moderator(s): Weon Kim
Panelist(s): Hyo-Suk Ahn, Hyo-In Choi
12:30 PM Jardiance, The First Successful Result for Heart Failure with Preserved Ejection Fraction
Lecturer: Wonjae Lee
12:50 PM Should Jardiance be Used as 1st Essential Medication for Heart Failure, Regardless of LVEF?
Lecturer: Kyung Hoon Cho
1:10 PM Discussion with Q&A